Details Basic Details Status Ongoing Last Updated Tuesday, April 7, 2026 Original Posting Date Tuesday, April 7, 2026 Purpose Drug and Outcome Analysis Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR No Analytic Code Link(s) (1) Risk of Gastrointestinal Hypomotility, Constipation, or GI dysmotility with Serious Complications, and Intentional Self-Harm in Individuals with Migraine Following Use of CGRP Inhibitors: A Propensity Score Matched Analysis